OS Therapies Incorporated
OSTX
$2.33
$0.146.39%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.34M | 3.69M | 2.10M | 1.23M | 383.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.84M | 5.00M | 2.97M | 2.44M | 779.80K |
| Operating Income | -4.84M | -5.00M | -2.97M | -2.44M | -779.80K |
| Income Before Tax | -4.54M | -3.88M | -2.99M | -2.88M | -1.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.54M | -3.88M | -2.99M | -2.88M | -1.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.54M | -3.88M | -2.99M | -2.88M | -1.56M |
| EBIT | -4.84M | -5.00M | -2.97M | -2.44M | -779.80K |
| EBITDA | -4.73M | -5.00M | -2.97M | -2.44M | -779.10K |
| EPS Basic | -0.18 | -0.18 | -0.23 | -0.18 | -0.26 |
| Normalized Basic EPS | -0.11 | -0.11 | -0.09 | -0.11 | -0.16 |
| EPS Diluted | -0.18 | -0.18 | -0.23 | -0.18 | -0.26 |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.09 | -0.11 | -0.16 |
| Average Basic Shares Outstanding | 25.11M | 21.25M | 21.76M | 15.90M | 5.99M |
| Average Diluted Shares Outstanding | 25.11M | 21.25M | 21.76M | 15.90M | 5.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |